Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 4, 2008, Pages

  Merchant, Michael L ^a,d   Cummins, Timothy D ^b   Wilkey, Daniel W ^a   Salyer, Sarah A ^a   Powell, David W ^a,b   Klein, Jon B ^a,b,c   Lederer, Eleanor D ^a,c,d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Donald Baxter Research Building   (United States)

Author keywords

Inflammation; Kidney stones; Lipoprotein; Osteopontin

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN D; APOLIPOPROTEIN E; ARYLSULFATASE; BLOOD CLOTTING FACTOR 10; CALGRANULIN A; CALGRANULIN B; CLUSTERIN; CYTOKERATIN 14; CYTOKERATIN 7; CYTOKERATIN 8; FATTY ACID BINDING PROTEIN; FIBRINOGEN; GLYCOPROTEIN; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 90; HISTONE H4; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MATRIX PROTEIN; MYELOPEROXIDASE; NUCLEOLIN; OSTEOPONTIN; PROTHROMBIN; SERUM AMYLOID P; SUPEROXIDE DISMUTASE; UNINDEXED DRUG; VITRONECTIN;

AMINO ACID SEQUENCE; ARTICLE; CALCIUM STONE; CELL DAMAGE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEPHROLITHIASIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; STONE ANALYSIS; STONE FORMATION; TANDEM MASS SPECTROMETRY;

EID: 57049167619     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00134.2008     Document Type: Article

References (37)

1. Barati MT, Merchant ML, Kain AB, Jevans AW, McLeish KR, Klein JB. Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice. Am J Physiol Renal Physiol 293: F1157-F1165, 2007.
2. Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol 291: F530-F536, 2006.
3. Canales BK, Anderson L, Higgins L, Slaton J, Roberts KP, Liu N, Monga M. Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 22: 1161-1167, 2008.
4. Christensen B, Petersen TE, Sorensen ES. Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J 411: 53-61, 2008.
5. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 115: 2598-2608, 2005.
6. De Yoreo JJ, Qiu SR, Hoyer JR. Molecular modulation of calcium oxalate crystallization. Am J Physiol Renal Physiol 291: F1123-F1131, 2006.
7. Doyle IR, Marshall VR, Dawson CJ, Ryall RL. Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro. Urol Res 23: 53-62, 1995.
8. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318, 2006.
9. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72: 1503-1511, 2007.
10. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616, 2003.
11. Fleischer TC, Weaver CM, McAfee KJ, Jennings JL, Link AJ. Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes. Genes Dev 20: 1294-1307, 2006.
12. Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL. Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol 294: F355-F361, 2008.
13. Hallson PC, Choong SK, Kasidas GP, Samuell CT. Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine. Br J Urol 80: 533-538, 1997.
14. Honda M, Yoshioka T, Yamaguchi S, Yoshimura K, Miyake O, Utsunomiya M, Koide T, Okuyama A. Characterization of protein components of human urinary crystal surface binding substance. Urol Res 25: 355-360, 1997.
15. Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107: 3564-3571, 2006.
16. Jensen ON, Podtelejnikov AV, Mann M. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. Anal Chem 69: 4741-4750, 1997.
17. Khan SR. Randall's plaque and renal injury. Kidney Int 71: 83-84, 2007.
18. Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98: e55-e60, 2004.
19. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 9: 1450-1482, 2004.
20. Knorle R, Schnierle P, Koch A, Buchholz NP, Hering F, Seiler H, Ackermann T, Rutishauser G. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy. Clin Chem 40: 1739-1743, 1994.
21. Kumar V, Farell G, Deganello S, Lieske JC. Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Am Soc Nephrol 14: 289-297, 2003.
22. Kumar V, Farell G, Lieske JC. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol 170: 221-225, 2003.
23. Kumar V, Yu S, Farell G, Toback FG, Lieske JC. Renal epithelial cells constitutively produce a protein that blocks adhesion of crystals to their surface. Am J Physiol Renal Physiol 287: F373-F383, 2004.
24. Lyons Ryall R, Fleming DE, Doyle IR, Evans NA, Dean CJ, Marshall VR. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation. J Struct Biol 134: 5-14, 2001.
25. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 367: 333-344, 2006.
26. Mushtaq S, Siddiqui AA, Naqvi ZA, Rattani A, Talati J, Palmberg C, Shafqat J. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta 384: 41-47, 2007.
27. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658, 2003.
28. Okada A, Nomura S, Saeki Y, Higashibata Y, Hamamoto S, Hirose M, Itoh Y, Yasui T, Tozawa K, Kohri K. Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res (May 27, 2008); doi: 10.1359/jbmr.080514.
29. Powell DW, Weaver CM, Jennings JL, McAfee KJ, He Y, Weil PA, Link AJ. Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol Cell Biol 24: 7249-7259, 2004.
30. Ryall RL. Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol 98: p37-p42, 2004.
31. Ryall RL, Grover PK, Thurgood LA, Chauvet MC, Fleming DE, van Bronswijk W. The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res 35: 1-14, 2007.
32. Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 68: 1808-1814, 2005.
33. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89: 426-430, 1992.
34. Sorokina EA, Wesson JA, Kleinman JG. An acidic peptide sequence of nucleolin-related protein can mediate the attachment of calcium oxalate to renal tubule cells. J Am Soc Nephrol 15: 2057-2065, 2004.
35. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823, 2003.
36. Stapleton AM, Ryall RL. Crystal matrix protein - getting blood out of a stone. Miner Electrolyte Metab 20: 399-409, 1994.
37. Verkoelen CF, Verhulst A. Proposed mechanisms in renal tubular crystal retention. Kidney Int 72: 13-18, 2007.